Cover Image

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial

Background: In addition to supportive therapy, antiviral therapy is an effective treatment for coronavirus disease 2019 (COVID-19).Objective: To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19 patients.Methods: We conducted a prospective, randomized, control...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Chen (Author), Yi Zhang (Author), Jianying Huang (Author), Ping Yin (Author), Zhenshun Cheng (Author), Jianyuan Wu (Author), Song Chen (Author), Yongxi Zhang (Author), Bo Chen (Author), Mengxin Lu (Author), Yongwen Luo (Author), Lingao Ju (Author), Jingyi Zhang (Author), Xinghuan Wang (Author)
Format: Book
Published: Frontiers Media S.A., 2021-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items